FindTrial
Sign In

Study on combined effect of oral intake of vasakadi kvatha and katakadi anjana eye drops in diabetic retinopathy

A Clinical Study on combined effect of Vasakadi kvatha and Kathakadi anjana in the management of Diabetic Retinopathy(Mehaja Timira)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/039922
Enrollment
30
Registered
2022-02-02
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E113- Type 2 diabetes mellitus with ophthalmic complications

Interventions

Intervention1: Vasakadi Kvatha and Katakadi anjana: Vasakadi kvatha 50ml twice daily before food and Katakadi anjana 1 drop for each eye twice daily for 60 days Control Intervention1: Nil: Nil

Sponsors

Dr S Vidyasagar badisa
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient aged between 20 to 70 yrs. 2. Type 1 or Type 2 diabetes mellitus 3. Patients with visual symptoms blurring of vision and floaters. 4. Fundoscopic findings revealing at least one micro aneurysm or intra retinal hemorrhage at least in two to three quadrants. 5. Presence of hard exudates. 6. Early mild IRMA 7. Patients reading and willing to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Known case of Gestational Diabetes mellitus. 2. Patients with complete loss of vision or sudden unexplained severe loss of vision. 3. Patients associated with other diagnosed systemic disorders renal, cerebrovascular disease. 4. Patients with known case of glaucoma and central cataract. 5. Patients with signs of retinal detachment, acute vitreous hemorrhage. 6. Other types of Retinopathies like-Hypertensive Retinopathy1, Retinopathies of blood dyscrasias.

Design outcomes

Primary

MeasureTime frame
To evaluate changes in best corrected visual acuityTimepoint: Baseline data 15th day 30th day 45th day 60th day—

Secondary

MeasureTime frame
To evaluate the amount of micro aneurysms.Timepoint: Baseline data 15th day 30th day 45th day 60th day—

Countries

India

Contacts

Public ContactDR S VIDYASAGAR BADISA

Sri Dharmasthala Manjunatheswara COllege of ayurveda and hospital

drashwinidhanpal@gmail.com9448222694

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026